elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33696974-D57420F2-2771-4EBB-9F0E-68B3195AC79A
Q33696974-D57420F2-2771-4EBB-9F0E-68B3195AC79A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33696974-D57420F2-2771-4EBB-9F0E-68B3195AC79A
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
P433
Q33696974-D57420F2-2771-4EBB-9F0E-68B3195AC79A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33696974-D57420F2-2771-4EBB-9F0E-68B3195AC79A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d73ad3d15159d9c4d13e7c15b9d6902a50ac913c
P433
1
http://www.w3.org/2001/XMLSchema#string